Article info

other Versions

PDF

Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism

Authors

  1. Correspondence to Professor Dr Johannes Bitzer, Chief Physician and Chairman Department of Obstetrics and Gynaecology, University Hospital Basel, Basel, Switzerland;Johannes.Bitzer{at}usb.ch
View Full Text

Citation

Bitzer J, Amy J, Beerthuizen R, et al
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism

Publication history

  • Received 15 March 2013
  • Accepted 18 March 2013
  • Published in print 10 April 2013.
  • Published online 12 April 2013.

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.